Biogaia

Biogaia EV/OCF

The EV/OCF (Enterprise Value to Operating Cash Flow) of Biogaia (BIOG B.ST) as of Nov 11, 2026 is 31.98. In the previous year, EV/OCF (Enterprise Value to Operating Cash Flow) was 25.14 — a change of 27.22% (higher).

EV/OCF

31.98

YoY

27.22%

Last updated:

EV/OCF (Enterprise Value to Operating Cash Flow) of Biogaia is 2025 31.98 . EV/OCF (Enterprise Value to Operating Cash Flow) of Biogaia was 2024 25.14 . It decreases by 27.22% higher compared to the previous year.

The Biogaia EV/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/OCF
Date
EV/OCF
Jan 1, 2018
56.16 SEK
Jan 1, 2019
70.38 SEK
Jan 1, 2020
41.40 SEK
Jan 1, 2021
41.12 SEK
Jan 1, 2022
28.61 SEK
Jan 1, 2023
21.28 SEK
Jan 1, 2024
25.14 SEK
Jan 1, 2025
31.98 SEK
The Biogaia EV/OCF history
YEAREV/OCFYoY
31.98+27.22%
25.14+18.14%
21.28-25.64%
28.61-30.42%
41.12-0.67%
41.40-41.17%
70.38+25.32%
56.16+21.96%
46.05-34.08%
69.85-20.86%
88.27+5.69%
83.51—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biogaia Stock analysis

What does Biogaia do? BioGaia AB generates revenue through its probiotic product segments, primarily featuring Limosilactobacillus reuteri strains. The Paediatrics segment sells drops, gut health tablets, oral rehydration solutions, and cultures for licensee products. The Adult Health segment offers gut health tablets, oral health lozenges, and cultures integrated into dairy products by licensees. The Other segment includes royalties from development projects and revenue from CapAble's packaging solutions. Products are marketed globally to consumers seeking health benefits from probiotics, with licensees distributing branded items under agreements. The company targets health-conscious consumers through direct sales and licensed partnerships. Paediatrics products focus on infant and child health, while Adult Health products address digestive and oral wellness. CapAble, a subsidiary, contributes through packaging solutions, and royalties from development projects provide additional income streams. All segments operate under BioGaia's brand, leveraging documented health benefits of their probiotic strains. Biogaia is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biogaia stock

EV/OCF (Enterprise Value to Operating Cash Flow) of Biogaia is 31.98 in 2025.

EV/OCF (Enterprise Value to Operating Cash Flow) of Biogaia changed from 25.14 to 31.98, representing a 27.22% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/OCF (Enterprise Value to Operating Cash Flow) Biogaia since 2006 – with annual values, charts, and detailed analysis.

EV/OCF compares enterprise value to operating cash flow, measuring how much investors pay per unit of cash generated from operations.

To evaluate EV/OCF (Enterprise Value to Operating Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/OCF (Enterprise Value to Operating Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/OCF (Enterprise Value to Operating Cash Flow)'s Biogaia with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Biogaia

All Key Metrics — Biogaia